Announcements Trials
Browse Landscape

Status

Unknown 4Recruiting 3Not yet recruiting 3Completed 2

Sponsor Class

OTHER 3

Study Type

Interventional 84Observational 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Hypersensitivity 1Colorectal Neoplasms 1

Interventions

Observation 23Blood Specimen Collection 20Drug Therapy 14Surveys and Questionnaires 10Surgical Procedures, Operative 8Immune Checkpoint Inhibitors 8Immunotherapy 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4tislelizumab 3envafolimab 3darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Letrozole 3Indocyanine Green 3Imatinib Mesylate 3Endosonography 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × tislelizumab × Clear all
NCT06504875 2024-07-17

Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer

The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting
23 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06504901 2024-07-17

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Shandong University

Not yet recruiting
200 enrolled
Breast

Hypersensitivity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡